401k Plan data: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN plan

BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 401k Plan overview

Plan Name	BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN
Plan identification number	002

BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Prototype plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion or notification letter; and under which a seperate funding medium (for example, a seperate trust or custodial account) is established for the use of each adopting employer.

401k Sponsoring company profile

BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C. has sponsored the creation of one or more 401k plans.

Company Name: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.

Employer identification number (EIN): 430907562

NAIC Classification: 621111
NAIC Description: Offices of Physicians (except Mental Health Specialists)

Form 5500 Filing Information

Submission information for form 5500 for 401k plan BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
002 2022-07-01 MICHAEL CURRY 2024-04-15
002 2021-07-01 ROGER ASBURY 2023-04-14
002 2020-07-01 MICHAEL CURRY 2022-04-14
002 2019-07-01 RICHARD COTTEN 2021-04-13
002 2018-07-01 RICHARD COTTEN 2020-04-08
002 2017-07-01 RICHARD COTTEN 2019-04-15
002 2016-07-01
002 2015-07-01
002 2014-07-01
002 2013-07-01
002 2012-07-01 HARRY WINFREY
002 2011-07-01 HARRY WINFREY
002 2009-07-01 HARRY WINFREY

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed
002	2022-07-01	MICHAEL CURRY	2024-04-15
002	2021-07-01	ROGER ASBURY	2023-04-14
002	2020-07-01	MICHAEL CURRY	2022-04-14
002	2019-07-01	RICHARD COTTEN	2021-04-13
002	2018-07-01	RICHARD COTTEN	2020-04-08
002	2017-07-01	RICHARD COTTEN	2019-04-15
002	2016-07-01
002	2015-07-01
002	2014-07-01
002	2013-07-01
002	2012-07-01	HARRY WINFREY
002	2011-07-01	HARRY WINFREY
002	2009-07-01	HARRY WINFREY

Plan Statistics for BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN

401k plan membership statisitcs for BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN

Measure Date Value
2022: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2022 401k membership
Total participants, beginning-of-year 2022-07-01 84
Total number of active participants reported on line 7a of the Form 5500 2022-07-01 0
Number of retired or separated participants receiving benefits 2022-07-01 3
Number of other retired or separated participants entitled to future benefits 2022-07-01 32
Total of all active and inactive participants 2022-07-01 35
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-07-01 1
Total participants 2022-07-01 36
Number of participants with account balances 2022-07-01 35
2021: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2021 401k membership
Total participants, beginning-of-year 2021-07-01 1
Total number of active participants reported on line 7a of the Form 5500 2021-07-01 1
Number of retired or separated participants receiving benefits 2021-07-01 7
Number of other retired or separated participants entitled to future benefits 2021-07-01 77
Total of all active and inactive participants 2021-07-01 85
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-07-01 1
Total participants 2021-07-01 86
Number of participants with account balances 2021-07-01 84
2020: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2020 401k membership
Total participants, beginning-of-year 2020-07-01 15
Total number of active participants reported on line 7a of the Form 5500 2020-07-01 1
Number of retired or separated participants receiving benefits 2020-07-01 8
Number of other retired or separated participants entitled to future benefits 2020-07-01 87
Total of all active and inactive participants 2020-07-01 96
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-07-01 1
Total participants 2020-07-01 97
Number of participants with account balances 2020-07-01 95
2019: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2019 401k membership
Total participants, beginning-of-year 2019-07-01 29
Total number of active participants reported on line 7a of the Form 5500 2019-07-01 15
Number of retired or separated participants receiving benefits 2019-07-01 11
Number of other retired or separated participants entitled to future benefits 2019-07-01 118
Total of all active and inactive participants 2019-07-01 144
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-07-01 1
Total participants 2019-07-01 145
Number of participants with account balances 2019-07-01 143
2018: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2018 401k membership
Total participants, beginning-of-year 2018-07-01 351
Total number of active participants reported on line 7a of the Form 5500 2018-07-01 29
Number of retired or separated participants receiving benefits 2018-07-01 12
Number of other retired or separated participants entitled to future benefits 2018-07-01 268
Total of all active and inactive participants 2018-07-01 309
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-07-01 1
Total participants 2018-07-01 310
Number of participants with account balances 2018-07-01 308
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-07-01 35
2017: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2017 401k membership
Total participants, beginning-of-year 2017-07-01 425
Total number of active participants reported on line 7a of the Form 5500 2017-07-01 238
Number of retired or separated participants receiving benefits 2017-07-01 7
Number of other retired or separated participants entitled to future benefits 2017-07-01 106
Total of all active and inactive participants 2017-07-01 351
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-07-01 1
Total participants 2017-07-01 352
Number of participants with account balances 2017-07-01 351
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-07-01 52
2016: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2016 401k membership
Total participants, beginning-of-year 2016-07-01 432
Total number of active participants reported on line 7a of the Form 5500 2016-07-01 330
Number of retired or separated participants receiving benefits 2016-07-01 7
Number of other retired or separated participants entitled to future benefits 2016-07-01 88
Total of all active and inactive participants 2016-07-01 425
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-07-01 0
Total participants 2016-07-01 425
Number of participants with account balances 2016-07-01 34
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-07-01 58
2015: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2015 401k membership
Total participants, beginning-of-year 2015-07-01 427
Total number of active participants reported on line 7a of the Form 5500 2015-07-01 352
Number of retired or separated participants receiving benefits 2015-07-01 1
Number of other retired or separated participants entitled to future benefits 2015-07-01 79
Total of all active and inactive participants 2015-07-01 432
Total participants 2015-07-01 432
Number of participants with account balances 2015-07-01 332
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-07-01 50
2014: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2014 401k membership
Total participants, beginning-of-year 2014-07-01 445
Total number of active participants reported on line 7a of the Form 5500 2014-07-01 354
Number of retired or separated participants receiving benefits 2014-07-01 1
Number of other retired or separated participants entitled to future benefits 2014-07-01 72
Total of all active and inactive participants 2014-07-01 427
Total participants 2014-07-01 427
Number of participants with account balances 2014-07-01 328
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-07-01 82
2013: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2013 401k membership
Total participants, beginning-of-year 2013-07-01 502
Total number of active participants reported on line 7a of the Form 5500 2013-07-01 441
Number of other retired or separated participants entitled to future benefits 2013-07-01 32
Total of all active and inactive participants 2013-07-01 473
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-07-01 1
Total participants 2013-07-01 474
Number of participants with account balances 2013-07-01 343
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-07-01 66
2012: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2012 401k membership
Total participants, beginning-of-year 2012-07-01 369
Total number of active participants reported on line 7a of the Form 5500 2012-07-01 479
Number of retired or separated participants receiving benefits 2012-07-01 0
Number of other retired or separated participants entitled to future benefits 2012-07-01 23
Total of all active and inactive participants 2012-07-01 502
Total participants 2012-07-01 502
Number of participants with account balances 2012-07-01 369
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-07-01 51
2011: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2011 401k membership
Total participants, beginning-of-year 2011-07-01 381
Total number of active participants reported on line 7a of the Form 5500 2011-07-01 327
Number of other retired or separated participants entitled to future benefits 2011-07-01 42
Total of all active and inactive participants 2011-07-01 369
Total participants 2011-07-01 369
Number of participants with account balances 2011-07-01 361
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-07-01 74
2009: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2009 401k membership
Total participants, beginning-of-year 2009-07-01 376
Total number of active participants reported on line 7a of the Form 5500 2009-07-01 377
Number of other retired or separated participants entitled to future benefits 2009-07-01 15
Total of all active and inactive participants 2009-07-01 392
Total participants 2009-07-01 392
Number of participants with account balances 2009-07-01 385
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-07-01 46

Measure	Date	Value
2022: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2022 401k membership
Total participants, beginning-of-year	2022-07-01	84
Total number of active participants reported on line 7a of the Form 5500	2022-07-01	0
Number of retired or separated participants receiving benefits	2022-07-01	3
Number of other retired or separated participants entitled to future benefits	2022-07-01	32
Total of all active and inactive participants	2022-07-01	35
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-07-01	1
Total participants	2022-07-01	36
Number of participants with account balances	2022-07-01	35
2021: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2021 401k membership
Total participants, beginning-of-year	2021-07-01	1
Total number of active participants reported on line 7a of the Form 5500	2021-07-01	1
Number of retired or separated participants receiving benefits	2021-07-01	7
Number of other retired or separated participants entitled to future benefits	2021-07-01	77
Total of all active and inactive participants	2021-07-01	85
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-07-01	1
Total participants	2021-07-01	86
Number of participants with account balances	2021-07-01	84
2020: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2020 401k membership
Total participants, beginning-of-year	2020-07-01	15
Total number of active participants reported on line 7a of the Form 5500	2020-07-01	1
Number of retired or separated participants receiving benefits	2020-07-01	8
Number of other retired or separated participants entitled to future benefits	2020-07-01	87
Total of all active and inactive participants	2020-07-01	96
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-07-01	1
Total participants	2020-07-01	97
Number of participants with account balances	2020-07-01	95
2019: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2019 401k membership
Total participants, beginning-of-year	2019-07-01	29
Total number of active participants reported on line 7a of the Form 5500	2019-07-01	15
Number of retired or separated participants receiving benefits	2019-07-01	11
Number of other retired or separated participants entitled to future benefits	2019-07-01	118
Total of all active and inactive participants	2019-07-01	144
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-07-01	1
Total participants	2019-07-01	145
Number of participants with account balances	2019-07-01	143
2018: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2018 401k membership
Total participants, beginning-of-year	2018-07-01	351
Total number of active participants reported on line 7a of the Form 5500	2018-07-01	29
Number of retired or separated participants receiving benefits	2018-07-01	12
Number of other retired or separated participants entitled to future benefits	2018-07-01	268
Total of all active and inactive participants	2018-07-01	309
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-07-01	1
Total participants	2018-07-01	310
Number of participants with account balances	2018-07-01	308
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-07-01	35
2017: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2017 401k membership
Total participants, beginning-of-year	2017-07-01	425
Total number of active participants reported on line 7a of the Form 5500	2017-07-01	238
Number of retired or separated participants receiving benefits	2017-07-01	7
Number of other retired or separated participants entitled to future benefits	2017-07-01	106
Total of all active and inactive participants	2017-07-01	351
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-07-01	1
Total participants	2017-07-01	352
Number of participants with account balances	2017-07-01	351
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-07-01	52
2016: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2016 401k membership
Total participants, beginning-of-year	2016-07-01	432
Total number of active participants reported on line 7a of the Form 5500	2016-07-01	330
Number of retired or separated participants receiving benefits	2016-07-01	7
Number of other retired or separated participants entitled to future benefits	2016-07-01	88
Total of all active and inactive participants	2016-07-01	425
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-07-01	0
Total participants	2016-07-01	425
Number of participants with account balances	2016-07-01	34
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-07-01	58
2015: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2015 401k membership
Total participants, beginning-of-year	2015-07-01	427
Total number of active participants reported on line 7a of the Form 5500	2015-07-01	352
Number of retired or separated participants receiving benefits	2015-07-01	1
Number of other retired or separated participants entitled to future benefits	2015-07-01	79
Total of all active and inactive participants	2015-07-01	432
Total participants	2015-07-01	432
Number of participants with account balances	2015-07-01	332
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-07-01	50
2014: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2014 401k membership
Total participants, beginning-of-year	2014-07-01	445
Total number of active participants reported on line 7a of the Form 5500	2014-07-01	354
Number of retired or separated participants receiving benefits	2014-07-01	1
Number of other retired or separated participants entitled to future benefits	2014-07-01	72
Total of all active and inactive participants	2014-07-01	427
Total participants	2014-07-01	427
Number of participants with account balances	2014-07-01	328
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-07-01	82
2013: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2013 401k membership
Total participants, beginning-of-year	2013-07-01	502
Total number of active participants reported on line 7a of the Form 5500	2013-07-01	441
Number of other retired or separated participants entitled to future benefits	2013-07-01	32
Total of all active and inactive participants	2013-07-01	473
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-07-01	1
Total participants	2013-07-01	474
Number of participants with account balances	2013-07-01	343
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-07-01	66
2012: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2012 401k membership
Total participants, beginning-of-year	2012-07-01	369
Total number of active participants reported on line 7a of the Form 5500	2012-07-01	479
Number of retired or separated participants receiving benefits	2012-07-01	0
Number of other retired or separated participants entitled to future benefits	2012-07-01	23
Total of all active and inactive participants	2012-07-01	502
Total participants	2012-07-01	502
Number of participants with account balances	2012-07-01	369
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-07-01	51
2011: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2011 401k membership
Total participants, beginning-of-year	2011-07-01	381
Total number of active participants reported on line 7a of the Form 5500	2011-07-01	327
Number of other retired or separated participants entitled to future benefits	2011-07-01	42
Total of all active and inactive participants	2011-07-01	369
Total participants	2011-07-01	369
Number of participants with account balances	2011-07-01	361
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-07-01	74
2009: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2009 401k membership
Total participants, beginning-of-year	2009-07-01	376
Total number of active participants reported on line 7a of the Form 5500	2009-07-01	377
Number of other retired or separated participants entitled to future benefits	2009-07-01	15
Total of all active and inactive participants	2009-07-01	392
Total participants	2009-07-01	392
Number of participants with account balances	2009-07-01	385
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-07-01	46

Financial Data on BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN

Measure	Date	Value
2023 : BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2023 401k financial data
Total income from all sources	2023-06-30	$267,771
Expenses. Total of all expenses incurred	2023-06-30	$2,531,453
Benefits paid (including direct rollovers)	2023-06-30	$2,408,850
Total plan assets at end of year	2023-06-30	$1,136,266
Total plan assets at beginning of year	2023-06-30	$3,399,948
Value of fidelity bond covering the plan	2023-06-30	$500,000
Expenses. Other expenses not covered elsewhere	2023-06-30	$122,603
Other income received	2023-06-30	$267,771
Net income (gross income less expenses)	2023-06-30	$-2,263,682
Net plan assets at end of year (total assets less liabilities)	2023-06-30	$1,136,266
Net plan assets at beginning of year (total assets less liabilities)	2023-06-30	$3,399,948
2022 : BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2022 401k financial data
Total income from all sources	2022-06-30	$285,769
Expenses. Total of all expenses incurred	2022-06-30	$1,171,769
Benefits paid (including direct rollovers)	2022-06-30	$390,624
Total plan assets at end of year	2022-06-30	$3,399,948
Total plan assets at beginning of year	2022-06-30	$4,285,948
Value of fidelity bond covering the plan	2022-06-30	$500,000
Expenses. Other expenses not covered elsewhere	2022-06-30	$781,145
Other income received	2022-06-30	$285,424
Net income (gross income less expenses)	2022-06-30	$-886,000
Net plan assets at end of year (total assets less liabilities)	2022-06-30	$3,399,948
Net plan assets at beginning of year (total assets less liabilities)	2022-06-30	$4,285,948
Total contributions received or receivable from employer(s)	2022-06-30	$345
2021 : BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-06-30	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-06-30	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-06-30	$0
Total income from all sources (including contributions)	2021-06-30	$1,826,012
Total loss/gain on sale of assets	2021-06-30	$0
Total of all expenses incurred	2021-06-30	$6,458,906
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-06-30	$2,934,981
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-06-30	$220
Value of total assets at end of year	2021-06-30	$4,285,948
Value of total assets at beginning of year	2021-06-30	$8,918,842
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-06-30	$3,523,925
Total interest from all sources	2021-06-30	$292,910
Total dividends received (eg from common stock, registered investment company shares)	2021-06-30	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-06-30	No
Was this plan covered by a fidelity bond	2021-06-30	Yes
Value of fidelity bond cover	2021-06-30	$500,000
If this is an individual account plan, was there a blackout period	2021-06-30	No
Were there any nonexempt tranactions with any party-in-interest	2021-06-30	No
Participant contributions at beginning of year	2021-06-30	$25,970
Income. Received or receivable in cash from other sources (including rollovers)	2021-06-30	$220
Administrative expenses (other) incurred	2021-06-30	$3,523,925
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-06-30	No
Value of net income/loss	2021-06-30	$-4,632,894
Value of net assets at end of year (total assets less liabilities)	2021-06-30	$4,285,948
Value of net assets at beginning of year (total assets less liabilities)	2021-06-30	$8,918,842
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-06-30	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-06-30	No
Were any leases to which the plan was party in default or uncollectible	2021-06-30	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-06-30	$4,285,948
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-06-30	$8,892,872
Interest earned on other investments	2021-06-30	$292,910
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-06-30	$1,532,882
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-06-30	No
Was there a failure to transmit to the plan any participant contributions	2021-06-30	No
Has the plan failed to provide any benefit when due under the plan	2021-06-30	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-06-30	$2,934,981
Did the plan have assets held for investment	2021-06-30	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-06-30	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-06-30	No
Opinion of an independent qualified public accountant for this plan	2021-06-30	Disclaimer
Accountancy firm name	2021-06-30	EVERS & COMPANY, CPA'S LLC
Accountancy firm EIN	2021-06-30	431121359
2020 : BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-06-30	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-06-30	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-06-30	$0
Total income from all sources (including contributions)	2020-06-30	$465,902
Total loss/gain on sale of assets	2020-06-30	$0
Total of all expenses incurred	2020-06-30	$1,802,494
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-06-30	$1,671,546
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-06-30	$83,841
Value of total assets at end of year	2020-06-30	$8,918,842
Value of total assets at beginning of year	2020-06-30	$10,255,434
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-06-30	$130,948
Total interest from all sources	2020-06-30	$442,354
Total dividends received (eg from common stock, registered investment company shares)	2020-06-30	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-06-30	No
Was this plan covered by a fidelity bond	2020-06-30	Yes
Value of fidelity bond cover	2020-06-30	$500,000
If this is an individual account plan, was there a blackout period	2020-06-30	No
Were there any nonexempt tranactions with any party-in-interest	2020-06-30	No
Contributions received from participants	2020-06-30	$78,985
Participant contributions at end of year	2020-06-30	$25,970
Participant contributions at beginning of year	2020-06-30	$96,804
Income. Received or receivable in cash from other sources (including rollovers)	2020-06-30	$4,856
Administrative expenses (other) incurred	2020-06-30	$130,948
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-06-30	No
Value of net income/loss	2020-06-30	$-1,336,592
Value of net assets at end of year (total assets less liabilities)	2020-06-30	$8,918,842
Value of net assets at beginning of year (total assets less liabilities)	2020-06-30	$10,255,434
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-06-30	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-06-30	No
Were any leases to which the plan was party in default or uncollectible	2020-06-30	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-06-30	$8,892,872
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-06-30	$10,158,630
Interest earned on other investments	2020-06-30	$442,354
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-06-30	$-60,293
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-06-30	Yes
Was there a failure to transmit to the plan any participant contributions	2020-06-30	No
Has the plan failed to provide any benefit when due under the plan	2020-06-30	No
Employer contributions (assets) at beginning of year	2020-06-30	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-06-30	$1,671,546
Did the plan have assets held for investment	2020-06-30	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-06-30	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-06-30	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2020-06-30	Yes
Opinion of an independent qualified public accountant for this plan	2020-06-30	Disclaimer
Accountancy firm name	2020-06-30	EVERS & COMPANY, CPA'S LLC
Accountancy firm EIN	2020-06-30	431121359
2019 : BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2019 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2019-06-30	$-156,252
Total unrealized appreciation/depreciation of assets	2019-06-30	$-156,252
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-06-30	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-06-30	$0
Total income from all sources (including contributions)	2019-06-30	$834,641
Total loss/gain on sale of assets	2019-06-30	$0
Total of all expenses incurred	2019-06-30	$7,349,643
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-06-30	$7,347,583
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-06-30	$228,339
Value of total assets at end of year	2019-06-30	$10,255,434
Value of total assets at beginning of year	2019-06-30	$16,770,436
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-06-30	$2,060
Total interest from all sources	2019-06-30	$760,640
Total dividends received (eg from common stock, registered investment company shares)	2019-06-30	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-06-30	No
Was this plan covered by a fidelity bond	2019-06-30	Yes
Value of fidelity bond cover	2019-06-30	$500,000
If this is an individual account plan, was there a blackout period	2019-06-30	No
Were there any nonexempt tranactions with any party-in-interest	2019-06-30	No
Contributions received from participants	2019-06-30	$228,339
Participant contributions at end of year	2019-06-30	$96,804
Participant contributions at beginning of year	2019-06-30	$484,349
Other income not declared elsewhere	2019-06-30	$1,914
Administrative expenses (other) incurred	2019-06-30	$2,060
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-06-30	No
Value of net income/loss	2019-06-30	$-6,515,002
Value of net assets at end of year (total assets less liabilities)	2019-06-30	$10,255,434
Value of net assets at beginning of year (total assets less liabilities)	2019-06-30	$16,770,436
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-06-30	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-06-30	No
Were any leases to which the plan was party in default or uncollectible	2019-06-30	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-06-30	$10,158,630
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-06-30	$15,822,313
Interest on participant loans	2019-06-30	$18,144
Interest earned on other investments	2019-06-30	$742,496
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-06-30	No
Was there a failure to transmit to the plan any participant contributions	2019-06-30	No
Has the plan failed to provide any benefit when due under the plan	2019-06-30	No
Contributions received in cash from employer	2019-06-30	$0
Employer contributions (assets) at end of year	2019-06-30	$0
Employer contributions (assets) at beginning of year	2019-06-30	$463,774
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-06-30	$7,347,583
Did the plan have assets held for investment	2019-06-30	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-06-30	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-06-30	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-06-30	Yes
Opinion of an independent qualified public accountant for this plan	2019-06-30	Disclaimer
Accountancy firm name	2019-06-30	LISA C. WRIGHT CPA, LLC
Accountancy firm EIN	2019-06-30	431868063
2018 : BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2018 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2018-06-30	$1,028,826
Total unrealized appreciation/depreciation of assets	2018-06-30	$1,028,826
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-06-30	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-06-30	$0
Total income from all sources (including contributions)	2018-06-30	$2,381,983
Total loss/gain on sale of assets	2018-06-30	$0
Total of all expenses incurred	2018-06-30	$2,225,640
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-06-30	$2,223,480
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-06-30	$709,429
Value of total assets at end of year	2018-06-30	$16,770,436
Value of total assets at beginning of year	2018-06-30	$16,614,093
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-06-30	$2,160
Total interest from all sources	2018-06-30	$642,799
Total dividends received (eg from common stock, registered investment company shares)	2018-06-30	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-06-30	No
Was this plan covered by a fidelity bond	2018-06-30	Yes
Value of fidelity bond cover	2018-06-30	$500,000
If this is an individual account plan, was there a blackout period	2018-06-30	No
Were there any nonexempt tranactions with any party-in-interest	2018-06-30	No
Contributions received from participants	2018-06-30	$245,654
Participant contributions at end of year	2018-06-30	$484,349
Participant contributions at beginning of year	2018-06-30	$499,590
Other income not declared elsewhere	2018-06-30	$929
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-06-30	No
Value of net income/loss	2018-06-30	$156,343
Value of net assets at end of year (total assets less liabilities)	2018-06-30	$16,770,436
Value of net assets at beginning of year (total assets less liabilities)	2018-06-30	$16,614,093
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-06-30	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-06-30	No
Were any leases to which the plan was party in default or uncollectible	2018-06-30	No
Investment advisory and management fees	2018-06-30	$2,160
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-06-30	$15,822,313
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-06-30	$15,665,518
Interest on participant loans	2018-06-30	$623,371
Income. Interest from loans (other than to participants)	2018-06-30	$19,428
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-06-30	No
Was there a failure to transmit to the plan any participant contributions	2018-06-30	No
Has the plan failed to provide any benefit when due under the plan	2018-06-30	No
Contributions received in cash from employer	2018-06-30	$463,775
Employer contributions (assets) at end of year	2018-06-30	$463,774
Employer contributions (assets) at beginning of year	2018-06-30	$448,985
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-06-30	$2,223,480
Did the plan have assets held for investment	2018-06-30	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-06-30	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-06-30	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-06-30	Yes
Opinion of an independent qualified public accountant for this plan	2018-06-30	Disclaimer
Accountancy firm name	2018-06-30	LISA C WRIGHT CPA LLC
Accountancy firm EIN	2018-06-30	431868063
2017 : BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2017 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2017-06-30	$1,693,029
Total unrealized appreciation/depreciation of assets	2017-06-30	$1,693,029
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-06-30	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-06-30	$0
Total income from all sources (including contributions)	2017-06-30	$2,966,892
Total loss/gain on sale of assets	2017-06-30	$0
Total of all expenses incurred	2017-06-30	$1,038,021
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-06-30	$1,035,741
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-06-30	$731,890
Value of total assets at end of year	2017-06-30	$16,614,093
Value of total assets at beginning of year	2017-06-30	$14,685,222
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-06-30	$2,280
Total interest from all sources	2017-06-30	$541,973
Total dividends received (eg from common stock, registered investment company shares)	2017-06-30	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-06-30	No
Was this plan covered by a fidelity bond	2017-06-30	Yes
Value of fidelity bond cover	2017-06-30	$500,000
If this is an individual account plan, was there a blackout period	2017-06-30	No
Were there any nonexempt tranactions with any party-in-interest	2017-06-30	No
Contributions received from participants	2017-06-30	$282,905
Participant contributions at end of year	2017-06-30	$499,590
Participant contributions at beginning of year	2017-06-30	$487,337
Income. Received or receivable in cash from other sources (including rollovers)	2017-06-30	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-06-30	No
Value of net income/loss	2017-06-30	$1,928,871
Value of net assets at end of year (total assets less liabilities)	2017-06-30	$16,614,093
Value of net assets at beginning of year (total assets less liabilities)	2017-06-30	$14,685,222
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-06-30	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-06-30	No
Were any leases to which the plan was party in default or uncollectible	2017-06-30	No
Investment advisory and management fees	2017-06-30	$2,280
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-06-30	$15,665,518
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-06-30	$13,720,312
Interest on participant loans	2017-06-30	$21,791
Interest earned on other investments	2017-06-30	$520,182
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-06-30	No
Was there a failure to transmit to the plan any participant contributions	2017-06-30	No
Has the plan failed to provide any benefit when due under the plan	2017-06-30	No
Contributions received in cash from employer	2017-06-30	$448,985
Employer contributions (assets) at end of year	2017-06-30	$448,985
Employer contributions (assets) at beginning of year	2017-06-30	$477,573
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-06-30	$1,035,741
Did the plan have assets held for investment	2017-06-30	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-06-30	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-06-30	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-06-30	Yes
Opinion of an independent qualified public accountant for this plan	2017-06-30	Disclaimer
Accountancy firm name	2017-06-30	WINFREY, CERTIFIED PUBLIC ACCOUNTAN
Accountancy firm EIN	2017-06-30	431686337
2016 : BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2016 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2016-06-30	$-435,926
Total unrealized appreciation/depreciation of assets	2016-06-30	$-435,926
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-06-30	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-06-30	$0
Total income from all sources (including contributions)	2016-06-30	$871,460
Total loss/gain on sale of assets	2016-06-30	$0
Total of all expenses incurred	2016-06-30	$610,093
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-06-30	$607,613
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-06-30	$730,648
Value of total assets at end of year	2016-06-30	$14,685,222
Value of total assets at beginning of year	2016-06-30	$14,423,855
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-06-30	$2,480
Total interest from all sources	2016-06-30	$576,738
Total dividends received (eg from common stock, registered investment company shares)	2016-06-30	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-06-30	No
Was this plan covered by a fidelity bond	2016-06-30	Yes
Value of fidelity bond cover	2016-06-30	$500,000
If this is an individual account plan, was there a blackout period	2016-06-30	No
Were there any nonexempt tranactions with any party-in-interest	2016-06-30	No
Contributions received from participants	2016-06-30	$249,677
Participant contributions at end of year	2016-06-30	$487,337
Participant contributions at beginning of year	2016-06-30	$492,319
Participant contributions at beginning of year	2016-06-30	$23,284
Income. Received or receivable in cash from other sources (including rollovers)	2016-06-30	$3,398
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-06-30	No
Value of net income/loss	2016-06-30	$261,367
Value of net assets at end of year (total assets less liabilities)	2016-06-30	$14,685,222
Value of net assets at beginning of year (total assets less liabilities)	2016-06-30	$14,423,855
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-06-30	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-06-30	No
Were any leases to which the plan was party in default or uncollectible	2016-06-30	No
Investment advisory and management fees	2016-06-30	$2,480
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-06-30	$13,720,312
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-06-30	$13,471,795
Interest on participant loans	2016-06-30	$21,202
Interest earned on other investments	2016-06-30	$555,536
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-06-30	No
Was there a failure to transmit to the plan any participant contributions	2016-06-30	No
Has the plan failed to provide any benefit when due under the plan	2016-06-30	No
Contributions received in cash from employer	2016-06-30	$477,573
Employer contributions (assets) at end of year	2016-06-30	$477,573
Employer contributions (assets) at beginning of year	2016-06-30	$436,457
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-06-30	$607,613
Did the plan have assets held for investment	2016-06-30	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-06-30	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-06-30	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-06-30	Yes
Opinion of an independent qualified public accountant for this plan	2016-06-30	Disclaimer
Accountancy firm name	2016-06-30	WINFREY, CERTIFIED PUBLIC ACCOUNTAN
Accountancy firm EIN	2016-06-30	431686337
2015 : BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2015 401k financial data
Unrealized appreciation/depreciation of real estate assets	2015-06-30	$51,118
Total unrealized appreciation/depreciation of assets	2015-06-30	$51,118
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-06-30	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-06-30	$0
Total income from all sources (including contributions)	2015-06-30	$1,359,659
Total loss/gain on sale of assets	2015-06-30	$0
Total of all expenses incurred	2015-06-30	$1,592,344
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-06-30	$1,589,844
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-06-30	$690,628
Value of total assets at end of year	2015-06-30	$14,423,855
Value of total assets at beginning of year	2015-06-30	$14,656,540
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-06-30	$2,500
Total interest from all sources	2015-06-30	$617,913
Total dividends received (eg from common stock, registered investment company shares)	2015-06-30	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-06-30	No
Was this plan covered by a fidelity bond	2015-06-30	Yes
Value of fidelity bond cover	2015-06-30	$500,000
If this is an individual account plan, was there a blackout period	2015-06-30	No
Were there any nonexempt tranactions with any party-in-interest	2015-06-30	No
Contributions received from participants	2015-06-30	$249,831
Participant contributions at end of year	2015-06-30	$492,319
Participant contributions at beginning of year	2015-06-30	$454,443
Participant contributions at end of year	2015-06-30	$23,284
Income. Received or receivable in cash from other sources (including rollovers)	2015-06-30	$4,340
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-06-30	No
Value of net income/loss	2015-06-30	$-232,685
Value of net assets at end of year (total assets less liabilities)	2015-06-30	$14,423,855
Value of net assets at beginning of year (total assets less liabilities)	2015-06-30	$14,656,540
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-06-30	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-06-30	No
Were any leases to which the plan was party in default or uncollectible	2015-06-30	No
Investment advisory and management fees	2015-06-30	$2,500
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-06-30	$13,471,795
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-06-30	$13,726,534
Interest on participant loans	2015-06-30	$17,676
Interest earned on other investments	2015-06-30	$600,237
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-06-30	No
Was there a failure to transmit to the plan any participant contributions	2015-06-30	No
Has the plan failed to provide any benefit when due under the plan	2015-06-30	No
Contributions received in cash from employer	2015-06-30	$436,457
Employer contributions (assets) at end of year	2015-06-30	$436,457
Employer contributions (assets) at beginning of year	2015-06-30	$475,563
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-06-30	$1,589,844
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2015-06-30	No
Did the plan have assets held for investment	2015-06-30	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-06-30	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-06-30	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-06-30	Yes
Opinion of an independent qualified public accountant for this plan	2015-06-30	Disclaimer
Accountancy firm name	2015-06-30	HARRY C. WINFREY, C.P.A., P.C.
Accountancy firm EIN	2015-06-30	431686337
2014 : BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2014 401k financial data
Unrealized appreciation/depreciation of real estate assets	2014-06-30	$1,742,415
Total unrealized appreciation/depreciation of assets	2014-06-30	$1,742,415
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-06-30	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-06-30	$0
Total income from all sources (including contributions)	2014-06-30	$2,984,969
Total loss/gain on sale of assets	2014-06-30	$0
Total of all expenses incurred	2014-06-30	$902,329
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-06-30	$899,588
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-06-30	$825,902
Value of total assets at end of year	2014-06-30	$14,656,540
Value of total assets at beginning of year	2014-06-30	$12,573,900
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-06-30	$2,741
Total interest from all sources	2014-06-30	$416,652
Total dividends received (eg from common stock, registered investment company shares)	2014-06-30	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-06-30	No
Was this plan covered by a fidelity bond	2014-06-30	Yes
Value of fidelity bond cover	2014-06-30	$500,000
If this is an individual account plan, was there a blackout period	2014-06-30	No
Were there any nonexempt tranactions with any party-in-interest	2014-06-30	No
Contributions received from participants	2014-06-30	$248,979
Participant contributions at end of year	2014-06-30	$454,443
Participant contributions at beginning of year	2014-06-30	$477,160
Income. Received or receivable in cash from other sources (including rollovers)	2014-06-30	$99,773
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-06-30	No
Value of net income/loss	2014-06-30	$2,082,640
Value of net assets at end of year (total assets less liabilities)	2014-06-30	$14,656,540
Value of net assets at beginning of year (total assets less liabilities)	2014-06-30	$12,573,900
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-06-30	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-06-30	No
Were any leases to which the plan was party in default or uncollectible	2014-06-30	No
Investment advisory and management fees	2014-06-30	$2,741
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-06-30	$13,726,534
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-06-30	$11,574,473
Interest on participant loans	2014-06-30	$18,222
Interest earned on other investments	2014-06-30	$398,430
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-06-30	Yes
Was there a failure to transmit to the plan any participant contributions	2014-06-30	No
Has the plan failed to provide any benefit when due under the plan	2014-06-30	No
Contributions received in cash from employer	2014-06-30	$477,150
Employer contributions (assets) at end of year	2014-06-30	$475,563
Employer contributions (assets) at beginning of year	2014-06-30	$522,267
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-06-30	$899,588
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2014-06-30	No
Did the plan have assets held for investment	2014-06-30	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-06-30	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-06-30	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-06-30	Yes
Opinion of an independent qualified public accountant for this plan	2014-06-30	Disclaimer
Accountancy firm name	2014-06-30	HARRY C. WINFREY, C.P.A., P.C.
Accountancy firm EIN	2014-06-30	431686337
2013 : BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2013 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2013-06-30	$1,060,212
Total unrealized appreciation/depreciation of assets	2013-06-30	$1,060,212
Total income from all sources (including contributions)	2013-06-30	$2,055,231
Total of all expenses incurred	2013-06-30	$421,369
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-06-30	$418,469
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-06-30	$723,143
Value of total assets at end of year	2013-06-30	$12,573,900
Value of total assets at beginning of year	2013-06-30	$10,940,038
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-06-30	$2,900
Total interest from all sources	2013-06-30	$271,876
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-06-30	No
Was this plan covered by a fidelity bond	2013-06-30	Yes
Value of fidelity bond cover	2013-06-30	$500,000
If this is an individual account plan, was there a blackout period	2013-06-30	No
Were there any nonexempt tranactions with any party-in-interest	2013-06-30	No
Contributions received from participants	2013-06-30	$228,958
Participant contributions at end of year	2013-06-30	$477,160
Participant contributions at beginning of year	2013-06-30	$425,431
Income. Received or receivable in cash from other sources (including rollovers)	2013-06-30	$43,564
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-06-30	No
Value of net income/loss	2013-06-30	$1,633,862
Value of net assets at end of year (total assets less liabilities)	2013-06-30	$12,573,900
Value of net assets at beginning of year (total assets less liabilities)	2013-06-30	$10,940,038
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-06-30	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-06-30	No
Were any leases to which the plan was party in default or uncollectible	2013-06-30	No
Investment advisory and management fees	2013-06-30	$2,900
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-06-30	$11,574,473
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-06-30	$10,044,281
Interest on participant loans	2013-06-30	$19,140
Interest earned on other investments	2013-06-30	$252,736
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-06-30	Yes
Was there a failure to transmit to the plan any participant contributions	2013-06-30	No
Has the plan failed to provide any benefit when due under the plan	2013-06-30	No
Contributions received in cash from employer	2013-06-30	$450,621
Employer contributions (assets) at end of year	2013-06-30	$522,267
Employer contributions (assets) at beginning of year	2013-06-30	$470,326
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-06-30	$418,469
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2013-06-30	No
Did the plan have assets held for investment	2013-06-30	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-06-30	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-06-30	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-06-30	Yes
Opinion of an independent qualified public accountant for this plan	2013-06-30	Disclaimer
Accountancy firm name	2013-06-30	HARRY C. WINFREY, C.P.A., P.C.
Accountancy firm EIN	2013-06-30	431686337
2012 : BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2012 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2012-06-30	$25,798
Total unrealized appreciation/depreciation of assets	2012-06-30	$25,798
Total income from all sources (including contributions)	2012-06-30	$959,418
Total of all expenses incurred	2012-06-30	$389,498
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-06-30	$387,170
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-06-30	$655,308
Value of total assets at end of year	2012-06-30	$10,940,038
Value of total assets at beginning of year	2012-06-30	$10,370,118
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-06-30	$2,328
Total interest from all sources	2012-06-30	$278,312
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-06-30	No
Was this plan covered by a fidelity bond	2012-06-30	Yes
Value of fidelity bond cover	2012-06-30	$500,000
If this is an individual account plan, was there a blackout period	2012-06-30	No
Were there any nonexempt tranactions with any party-in-interest	2012-06-30	No
Contributions received from participants	2012-06-30	$217,754
Participant contributions at end of year	2012-06-30	$425,431
Participant contributions at beginning of year	2012-06-30	$354,262
Participant contributions at beginning of year	2012-06-30	$13,189
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-06-30	No
Value of net income/loss	2012-06-30	$569,920
Value of net assets at end of year (total assets less liabilities)	2012-06-30	$10,940,038
Value of net assets at beginning of year (total assets less liabilities)	2012-06-30	$10,370,118
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-06-30	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-06-30	No
Were any leases to which the plan was party in default or uncollectible	2012-06-30	No
Investment advisory and management fees	2012-06-30	$2,328
Value of interest in registered invesment companies (eg mutual funds) at end of year	2012-06-30	$10,044,281
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2012-06-30	$9,567,687
Interest on participant loans	2012-06-30	$16,329
Interest earned on other investments	2012-06-30	$261,983
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-06-30	Yes
Was there a failure to transmit to the plan any participant contributions	2012-06-30	No
Has the plan failed to provide any benefit when due under the plan	2012-06-30	No
Contributions received in cash from employer	2012-06-30	$437,554
Employer contributions (assets) at end of year	2012-06-30	$470,326
Employer contributions (assets) at beginning of year	2012-06-30	$434,980
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-06-30	$387,170
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2012-06-30	No
Did the plan have assets held for investment	2012-06-30	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-06-30	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-06-30	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-06-30	Yes
Opinion of an independent qualified public accountant for this plan	2012-06-30	Disclaimer
Accountancy firm name	2012-06-30	HARRY C. WINFREY, C.P.A., P.C.
Accountancy firm EIN	2012-06-30	431686337
2011 : BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2011 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2011-06-30	$1,277,403
Total unrealized appreciation/depreciation of assets	2011-06-30	$1,277,403
Total income from all sources (including contributions)	2011-06-30	$2,155,198
Total of all expenses incurred	2011-06-30	$832,030
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2011-06-30	$830,350
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2011-06-30	$636,653
Value of total assets at end of year	2011-06-30	$10,370,118
Value of total assets at beginning of year	2011-06-30	$9,046,950
Total of administrative expenses incurred including professional, contract, advisory and management fees	2011-06-30	$1,680
Total interest from all sources	2011-06-30	$241,142
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2011-06-30	No
Was this plan covered by a fidelity bond	2011-06-30	Yes
Value of fidelity bond cover	2011-06-30	$500,000
If this is an individual account plan, was there a blackout period	2011-06-30	No
Were there any nonexempt tranactions with any party-in-interest	2011-06-30	No
Contributions received from participants	2011-06-30	$201,673
Participant contributions at end of year	2011-06-30	$354,262
Participant contributions at beginning of year	2011-06-30	$368,749
Participant contributions at end of year	2011-06-30	$13,189
Participant contributions at beginning of year	2011-06-30	$14,978
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-06-30	No
Value of net income/loss	2011-06-30	$1,323,168
Value of net assets at end of year (total assets less liabilities)	2011-06-30	$10,370,118
Value of net assets at beginning of year (total assets less liabilities)	2011-06-30	$9,046,950
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2011-06-30	No
Were any loans by the plan or fixed income obligations due to the plan in default	2011-06-30	No
Were any leases to which the plan was party in default or uncollectible	2011-06-30	No
Investment advisory and management fees	2011-06-30	$1,680
Value of interest in registered invesment companies (eg mutual funds) at end of year	2011-06-30	$9,567,687
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2011-06-30	$8,218,049
Interest on participant loans	2011-06-30	$16,848
Interest earned on other investments	2011-06-30	$224,294
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2011-06-30	Yes
Was there a failure to transmit to the plan any participant contributions	2011-06-30	No
Has the plan failed to provide any benefit when due under the plan	2011-06-30	No
Contributions received in cash from employer	2011-06-30	$434,980
Employer contributions (assets) at end of year	2011-06-30	$434,980
Employer contributions (assets) at beginning of year	2011-06-30	$445,174
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2011-06-30	$830,350
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2011-06-30	No
Did the plan have assets held for investment	2011-06-30	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-06-30	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2011-06-30	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2011-06-30	Yes
Opinion of an independent qualified public accountant for this plan	2011-06-30	Disclaimer
Accountancy firm name	2011-06-30	HARRY C. WINFREY, C.P.A., P.C.
Accountancy firm EIN	2011-06-30	431686337

Form 5500 Responses for BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN

2022: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2022 form 5500 responses
2022-07-01	Type of plan entity	Single employer plan
2022-07-01	Submission has been amended	No
2022-07-01	This submission is the final filing	No
2022-07-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-07-01	Plan is a collectively bargained plan	No
2022-07-01	Plan funding arrangement – Trust	Yes
2022-07-01	Plan benefit arrangement - Trust	Yes
2021: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2021 form 5500 responses
2021-07-01	Type of plan entity	Single employer plan
2021-07-01	Submission has been amended	No
2021-07-01	This submission is the final filing	No
2021-07-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-07-01	Plan is a collectively bargained plan	No
2021-07-01	Plan funding arrangement – Trust	Yes
2021-07-01	Plan benefit arrangement - Trust	Yes
2020: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2020 form 5500 responses
2020-07-01	Type of plan entity	Single employer plan
2020-07-01	Submission has been amended	No
2020-07-01	This submission is the final filing	No
2020-07-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-07-01	Plan is a collectively bargained plan	No
2020-07-01	Plan funding arrangement – Trust	Yes
2020-07-01	Plan benefit arrangement - Trust	Yes
2019: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2019 form 5500 responses
2019-07-01	Type of plan entity	Single employer plan
2019-07-01	Submission has been amended	No
2019-07-01	This submission is the final filing	No
2019-07-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-07-01	Plan is a collectively bargained plan	No
2019-07-01	Plan funding arrangement – Trust	Yes
2019-07-01	Plan benefit arrangement - Trust	Yes
2018: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2018 form 5500 responses
2018-07-01	Type of plan entity	Single employer plan
2018-07-01	Submission has been amended	No
2018-07-01	This submission is the final filing	No
2018-07-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-07-01	Plan is a collectively bargained plan	No
2018-07-01	Plan funding arrangement – Trust	Yes
2018-07-01	Plan benefit arrangement - Trust	Yes
2017: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2017 form 5500 responses
2017-07-01	Type of plan entity	Single employer plan
2017-07-01	Submission has been amended	No
2017-07-01	This submission is the final filing	No
2017-07-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-07-01	Plan is a collectively bargained plan	No
2017-07-01	Plan funding arrangement – Trust	Yes
2017-07-01	Plan benefit arrangement - Trust	Yes
2016: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2016 form 5500 responses
2016-07-01	Type of plan entity	Single employer plan
2016-07-01	Submission has been amended	No
2016-07-01	This submission is the final filing	No
2016-07-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-07-01	Plan is a collectively bargained plan	No
2016-07-01	Plan funding arrangement – Trust	Yes
2016-07-01	Plan benefit arrangement - Trust	Yes
2015: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2015 form 5500 responses
2015-07-01	Type of plan entity	Single employer plan
2015-07-01	Submission has been amended	No
2015-07-01	This submission is the final filing	No
2015-07-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-07-01	Plan is a collectively bargained plan	No
2015-07-01	Plan funding arrangement – Trust	Yes
2015-07-01	Plan benefit arrangement - Trust	Yes
2014: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2014 form 5500 responses
2014-07-01	Type of plan entity	Single employer plan
2014-07-01	Submission has been amended	No
2014-07-01	This submission is the final filing	No
2014-07-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-07-01	Plan is a collectively bargained plan	No
2014-07-01	Plan funding arrangement – Trust	Yes
2014-07-01	Plan benefit arrangement - Trust	Yes
2013: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2013 form 5500 responses
2013-07-01	Type of plan entity	Single employer plan
2013-07-01	Submission has been amended	No
2013-07-01	This submission is the final filing	No
2013-07-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-07-01	Plan is a collectively bargained plan	No
2013-07-01	Plan funding arrangement – Trust	Yes
2013-07-01	Plan benefit arrangement - Trust	Yes
2012: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2012 form 5500 responses
2012-07-01	Type of plan entity	Single employer plan
2012-07-01	Submission has been amended	No
2012-07-01	This submission is the final filing	No
2012-07-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-07-01	Plan is a collectively bargained plan	No
2012-07-01	Plan funding arrangement – Trust	Yes
2012-07-01	Plan benefit arrangement - Trust	Yes
2011: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2011 form 5500 responses
2011-07-01	Type of plan entity	Single employer plan
2011-07-01	Submission has been amended	No
2011-07-01	This submission is the final filing	No
2011-07-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-07-01	Plan is a collectively bargained plan	No
2011-07-01	Plan funding arrangement – Trust	Yes
2011-07-01	Plan benefit arrangement - Trust	Yes
2009: BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.-RESTATED PROFIT SHARING PLAN 2009 form 5500 responses
2009-07-01	Type of plan entity	Single employer plan
2009-07-01	Submission has been amended	No
2009-07-01	This submission is the final filing	No
2009-07-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-07-01	Plan is a collectively bargained plan	No
2009-07-01	Plan funding arrangement – Trust	Yes
2009-07-01	Plan benefit arrangement - Trust	Yes

Potentially related plans

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	BOYCE & BYNUM PATHOLOGY LABORATORIES, P.C.
Employer identification number (EIN):	430907562
NAIC Classification:	621111
NAIC Description:	Offices of Physicians (except Mental Health Specialists)